Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
49.1M
-
Shares change
-
+16.7M
-
Total reported value, excl. options
-
$203M
-
Value change
-
+$69.8M
-
Put/Call ratio
-
0.28
-
Number of buys
-
53
-
Number of sells
-
-36
-
Price
-
$4.14
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2024
117 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q1 2024.
Summit Therapeutics Inc. - COM (SMMT) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.1M shares
.
Largest 10 shareholders include BlackRock Inc. (9.82M shares), STATE STREET CORP (8.11M shares), FMR LLC (7.97M shares), VANGUARD GROUP INC (7.27M shares), GEODE CAPITAL MANAGEMENT, LLC (3.15M shares), NORTHERN TRUST CORP (1.07M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.02M shares), MORGAN STANLEY (693K shares), GOLDMAN SACHS GROUP INC (681K shares), and Rafferty Asset Management, LLC (650K shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.